Search

everythinglearnresearchcommunity

for

Search:↓

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Targeting the TRPV4 channel may help treat intestinal diseases.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

New acne treatments like clascoterone and minocycline foam are effective, and using antibiotics carefully is important to avoid resistance.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Neutrophils are important for causing chronic itch in atopic dermatitis, and blocking the CXCR3 receptor may reduce this itch.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Existing drugs are being repurposed to treat cardiometabolic disorders, which is safer, faster, and cheaper than developing new drugs.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Glucocorticoids and thyroid hormones together are essential for fetal fat development.

A substance from Caulerpa racemosa seaweed may protect against skin damage caused by air pollution by reducing oxidative stress and cell death.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Adrenocorticotropic hormone inhibits growth and affects body composition in male rats.

Cetirizine is effective and safe for treating various allergies, with personalized dosing improving its use.

Clascoterone cream 1% is effective and well-tolerated for treating acne and other related conditions.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.